Cover Story
July 2013

STATINS: Are the side effects from cholesterol-lowering drugs worth the risk?

When the Food and Drug Administration (FDA) announced labeling changes to cholesterol-lowering statins in February of last year, the media were quick to sound the alarm. Headlines proclaimed that stat...

Read More

Features